Lipid management in patients presenting with acute coronary syndromes: a review
Despite many improvements in its prevention and management, acute coronary syndrome
(ACS) remains a major cause of morbidity and mortality in the developed world. Lipid …
(ACS) remains a major cause of morbidity and mortality in the developed world. Lipid …
Diagnosis and management of acute coronary syndrome: What is new and why? insight from the 2020 european society of cardiology guidelines
P Guedeney, JP Collet - Journal of Clinical Medicine, 2020 - mdpi.com
The management of acute coronary syndrome (ACS) has been at the center of an
impressive amount of research leading to a significant improvement in outcomes over the …
impressive amount of research leading to a significant improvement in outcomes over the …
The effect of statin adherence on patients with type 2 diabetes after percutaneous coronary intervention for acute coronary syndrome
L Zhang, W Wang, F Man, Q Pan, L Guo - Cardiovascular Drugs and …, 2023 - Springer
Purpose To investigate the effect of long-term statin adherence among patients with type 2
diabetes mellitus (T2DM) after percutaneous coronary intervention (PCI) for acute coronary …
diabetes mellitus (T2DM) after percutaneous coronary intervention (PCI) for acute coronary …
Epidemiology, treatment patterns and outcomes in patients with coronary or lower extremity artery disease in France
P Guedeney, V Aboyans, F Dalon, D Oksen… - Archives of …, 2019 - Elsevier
Background There is a dearth of updated epidemiological data on the prevalence and
annual incidence of coronary artery disease (CAD) and lower extremity artery disease …
annual incidence of coronary artery disease (CAD) and lower extremity artery disease …
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: further evidence fuelling the dual target concept
W Koenig - European heart journal, 2020 - academic.oup.com
Over the last 30 years, vascular biology has provided unequivocal evidence that
inflammatory processes play a significant role during the initiation of the atherosclerotic …
inflammatory processes play a significant role during the initiation of the atherosclerotic …
[HTML][HTML] Остаточный риск у пациентов с атеросклеротическими кардиоваскулярными заболеваниями
ЕВ Хазова, ОВ Булашова - Кардиоваскулярная терапия и …, 2023 - cyberleninka.ru
Остаточный риск у пациентов с атеросклерозом, несмотря на спорные моменты его
понимания, остается актуальной проблемой современной кардиологии. В статье …
понимания, остается актуальной проблемой современной кардиологии. В статье …
Statin eligibility based on the ACC/AHA guidelines among Middle Eastern patients with diabetes mellitus presenting with acute myocardial infarction
MI Jarrah, MJ Ababneh, LI Tawalbeh… - Annals of Medicine …, 2021 - journals.lww.com
Background: Statin eligibility based on the American College of Cardiology/American Heart
Association cholesterol guidelines among patients with diabetes admitted with first time …
Association cholesterol guidelines among patients with diabetes admitted with first time …
LDLc and residual risk reduction with fixed-dose combination rosuvastatin-ezetimibe in patients with acute vs. chronic coronary syndrome not candidates for PCSK9 …
A Cordero, D Escribano, MA Quintanilla, MD Masiá… - 2022 - researchsquare.com
Background: Most patients with coronary heart disease (CHD) might be candidates for statin
plus ezetimibe combination to achieve low-density lipoprotein cholesterol (LDLc)< 55 mg/dl …
plus ezetimibe combination to achieve low-density lipoprotein cholesterol (LDLc)< 55 mg/dl …